EdgarLookup
SC 13G/A

AMENDMENT NO. 2 TO SCHEDULE 13G

Company
Altamira Therapeutics Ltd.
Filed
February 14, 2017
Accession Number
0000947871-17-000125
View Document ↗ View on SEC.gov ↗